David Kerr

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial

Janet James, Peter Thomas, David Cavan et al. · BMJ · 2004 · 821 citations · Full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

Dorothee Deiss, Jan Bolinder, Jean-Pierre Riveline et al. · Diabetes Care · 2006 · 542 citations · Full text

Type 1, Diabetes Management, Health Policy +15

Spatially disaggregated population estimates in the absence of national population and housing census data

Nicola Wardrop, Warren C. Jochem, Tomas J. Bird et al. · Proceedings of the National Academy of Sciences · 2018 · 302 citations · Full text

Population Estimates, Population Numbers, Population Science +21